Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aastrom raises $13.5 million

ASTM raised $13.5 million in a registered direct offering of 11.8

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE